China SXT Pharmaceuticals, Inc. Other Receivables
Financial Statements › Balance Sheet › Assets › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2026-07-01
- 2026-03-31: Other Receivables $184.00K.
- 2025-09-30: Other Receivables $119.08K.
- 2025-03-31: Other Receivables $108.28K.
- 2024-03-31: Other Receivables $83.63K.
| Period end | Other Receivables |
|---|---|
| 2026-03-31 | $184.00K 20-F · filed 2026-07-01 |
| 2025-09-30 | $119.08K 6-K · filed 2025-12-31 |
| 2025-03-31 | $108.28K 20-F · filed 2026-07-01 |
| 2024-03-31 | $83.63K 20-F · filed 2025-07-31 |
| 2022-09-30 | $583.15K 6-K · filed 2023-02-24 |
| 2022-03-31 | $288.94K 20-F/A · filed 2023-05-19 |
| 2021-09-30 | $194.84K 6-K · filed 2022-01-14 |
| 2021-03-31 | $180.37K 20-F/A · filed 2023-05-19 |
| 2020-09-30 | $296.01K 6-K · filed 2021-01-28 |
| 2020-03-31 | $144.35K 20-F · filed 2021-08-13 |
| 2019-09-30 | $195.62K 6-K/A · filed 2020-05-22 |
| 2019-03-31 | $36.72K 20-F · filed 2020-07-31 |
| 2018-03-31 | $37.21K 20-F · filed 2019-08-15 |